InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Sazdanoff Catherine, Director. Officer active across 1 company, notably Meridian Bioscience INC. In total, 2 disclosures have been published. History available since 26 January 2022. The latest transaction was disclosed on 26 January 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Catherine Sazdanoff is a Board Member at Meridian Bioscience Inc. She contributes to overseeing the company's activities and developing strategies for its growth. Her experience in the life sciences sector allows her to provide valuable insights to the board.